Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dL
Phase 3
Withdrawn
- Conditions
- Severe Hypertriglyceridemia
- Interventions
- Drug: PlaceboDrug: MAT9001 (omega-3 pentaenoic acid)
- First Posted Date
- 2020-12-10
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Matinas Biopharma, Inc
- Registration Number
- NCT04662528
A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
Phase 1
Completed
- Conditions
- Hypertriglyceridemia
- Interventions
- Drug: Drug Omega 3
- First Posted Date
- 2014-12-05
- Last Posted Date
- 2020-10-12
- Lead Sponsor
- Matinas Biopharma, Inc
- Target Recruit Count
- 48
- Registration Number
- NCT02310022
- Locations
- 🇨🇦
Pharma Medica Reserach Inc, Toronto, Ontario, Canada
News
No news found